Literature DB >> 8627176

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

R Biassoni1, C Cantoni, M Falco, S Verdiani, C Bottino, M Vitale, R Conte, A Poggi, A Moretta, L Moretta.   

Abstract

Natural killer cells express clonally distributed receptors specific for major histocompatibility complex class I molecules. The human leukocyte antigen (HLA)-C-specific receptors have been molecularly identified and cloned. They exist not only as inhibitory (p58) but also as activatory (p50) receptors. Here we show that p50 and p58 are highly homologous in their extracellular regions formed by two Ig-like domains. In contrast, major differences exist in their transmembrane and cytoplasmic portions. Whereas p 58 displays a 76-84-amino acid cytoplasmic tail containing an unusual antigen receptor activation motif, p50 is characterized by a shorter 39-amino acid tail. In addition, whereas p58 has a nonpolar transmembrane portion, p50 contains the charged amino acid Lys. These data strongly suggest that receptors with identical HLA-C allele specificity can mediate functions of opposite sign owing to their different transmembrane/cytoplasmic portions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627176      PMCID: PMC2192451          DOI: 10.1084/jem.183.2.645

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.

Authors:  C Naper; J T Vaage; D Lambracht; G Løvik; G W Butcher; K Wonigeit; B Rolstad
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

Review 3.  Signal transduction by lymphocyte antigen receptors.

Authors:  A Weiss; D R Littman
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

4.  Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.

Authors:  J J Pérez-Villar; I Melero; A Rodríguez; M Carretero; J Aramburu; S Sivori; A M Orengo; A Moretta; M López-Botet
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

5.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).

Authors:  E Ciccone; D Pende; O Viale; A Than; C Di Donato; A M Orengo; R Biassoni; S Verdiani; A Amoroso; A Moretta
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

Review 6.  Hybrid resistance: 'negative' and 'positive' signaling of murine natural killer cells.

Authors:  M Bennett; Y Y Yu; E Stoneman; R M Rembecki; P A Mathew; K F Lindahl; V Kumar
Journal:  Semin Immunol       Date:  1995-04       Impact factor: 11.130

7.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

Authors:  A Moretta; C Bottino; D Pende; G Tripodi; G Tambussi; O Viale; A Orengo; M Barbaresi; A Merli; E Ciccone
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

8.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

Authors:  A Moretta; M Vitale; C Bottino; A M Orengo; L Morelli; R Augugliaro; M Barbaresi; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  65 in total

1.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Transmembrane T-cell receptor peptides inhibit B- and natural killer-cell function.

Authors:  Nghi T Huynh; Rosemary A Ffrench; Ross A Boadle; Nicholas Manolios
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.

Authors:  Catharina Gross; Ingo G H Schmidt-Wolf; Srinivas Nagaraj; Robert Gastpar; Joachim Ellwart; Leoni A Kunz-Schughart; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

4.  Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors.

Authors:  Jianwen Feng; David Garrity; Matthew E Call; Howell Moffett; Kai W Wucherpfennig
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

Review 5.  Dendritic cell interactions with NK cells from different tissues.

Authors:  Guido Ferlazzo; Christian Münz
Journal:  J Clin Immunol       Date:  2009-03-12       Impact factor: 8.317

Review 6.  Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.

Authors:  Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

7.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

8.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Authors:  Steven G E Marsh; Peter Parham; Bo Dupont; Daniel E Geraghty; John Trowsdale; Derek Middleton; Carlos Vilches; Mary Carrington; Campbell Witt; Lisbeth A Guethlein; Heather Shilling; Christian A Garcia; Katharine C Hsu; Hester Wain
Journal:  Immunogenetics       Date:  2003-06-28       Impact factor: 2.846

Review 9.  Biology and clinical effects of natural killer cells in allogeneic transplantation.

Authors:  Jonathan E Benjamin; Saar Gill; Robert S Negrin
Journal:  Curr Opin Oncol       Date:  2010-03       Impact factor: 3.645

10.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.